Irwin H. Slater - Concepedia

Author

Irwin H. Slater

Also Known As

I H SLATER, I H Slater, I. H. SLATER, I. H. Slater, I. Slater, I.H. SLATER, I.H. Slater, IRWIN H. SLATER, Irwin H. Slater, Irwin Slater

Publications

865

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Irwin H. Slater is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	369
2	Health Sciences	3	3	91
3	Social Sciences	3	3	104
4	Anesthesia	3	3	58
5	Natural Sciences	2	2	37

Irwin H. Slater

Publications

817

Citations

H-Index

Page 1

	Year	Citations
BLOCKING OF INHIBITORY ADRENERGIC RECEPTORS BY A DICHLORO ANALOG OF ISOPROTERENOL C.E. Powell, Irwin H. Slater, Lester LeCompte, Journal of Pharmacology and Experimental Therapeutics	1958	401
Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle Marlene L. Cohen, Emily Rosing, Kathryn S. Wiley, Life Sciences Molecular PharmacologyAdrenal GlandMolecular PhysiologyMedicinePhysiology	1978	80
Amitriptyline and nortriptyline as antagonists of central and peripheral cholinergic activation Robert C. Rathbun, Irwin H. Slater Psychopharmacology MedicinePhysiologyNeurotransmitterExperimental PharmacologyPharmacotherapy	1963	61
Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake Irwin H. Slater, G. T. Jones, R Andrew Moore Neuropharmacology Specific InhibitorSleepSleep DisorderNeurophysiologyMedicine	1978	59
A comparison of thalidomide and pentobarbital - new methods for identifying novel hypnotic drugs. Robert C.A. Frederickson, Irwin H. Slater, W E Dusenberry, Journal of Pharmacology and Experimental Therapeutics	1977	26
Role of 5-hydroxytryptaminergic and adrenergic mechanism in antagonism of reserpine-induced hypothermia in mice Irwin H. Slater, Robert C. Rathbun, Richard W. Kattau Journal of Pharmacy and Pharmacology Molecular PharmacologyNeurophysiologyAdrenergic MechanismMedicinePhysiology	1979	26
N-Substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relations. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation Jack Mills, Richard W. Kattau, Irwin H. Slater, Journal of Medicinal Chemistry N-substituted CyclopropylaminesPharmacotherapyChemical BiologyExperimental PharmacologyMolecular Pharmacology	1968	22
<i>In vitro </i>Relaxation of Arteries and Veins by Prazosin: Alpha-Adrenergic Blockade with No Direct Vasodilation Marlene L. Cohen, Kathryn S. Wiley, Irwin H. Slater Journal of Vascular Research HypertensionCardiovascular PharmacologyPharmacotherapyPrazosin LowersNo Direct Vasodilation	1979	21
THE ACTION OF SOME DERIVATIVES OF BETA-ERYTHROIDINE ON PERIPHERAL NEURO-EFFECTOR SYSTEMS D. Megirian, Daniel E. Leary, Irwin H. Slater Journal of Pharmacology and Experimental Therapeutics	1955	21
Mode of Action of Phenaglycodol, A New Neurosedative Agent Irwin H. Slater, G. T. Jones, Wilma K Young Experimental Biology and Medicine Reflex ArcsAnesthetic MechanismPharmacotherapyBlood PressureSocial Sciences	1956	19

Page 1